EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Proteomic approaches advancing targeted protein degradation

Gajanan Sathe, Gopal P Sapkota

Trends in Pharmacological Sciences · 2023-11 · 44 (11) · 786-801

DOI: 10.1016/j.tips.2023.08.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2023-11. Verfasst von Gajanan Sathe und 1 weiteren Autor:innen. Beteiligte Einrichtung: MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK. Electronic address: gsathe001…. Hauptthemen laut MEDLINE: Proteomics, Proteolysis Targeting Chimera. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted protein degradation (TPD) is an emerging modality for research and therapeutics. Most TPD approaches harness cellular ubiquitin-dependent proteolytic pathways. Proteolysis-targeting chimeras (PROTACs) and molecular glue (MG) degraders (MGDs) represent the most advanced TPD approaches, with some already used in clinical settings. Despite these advances, TPD still faces many challenges, pertaining to both the development of effective, selective, and tissue-penetrant degraders and understanding their mode of action. In this review, we focus on progress made in addressing these challenges. In particular, we discuss the utility and application of recent proteomic approaches as indispensable tools to enable insights into degrader development, including target engagement, degradation selectivity, efficacy, safety, and mode of action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsProteolysis Targeting ChimeraHumansProteolysisUbiquitin-Protein Ligases

Stichwörter der Autor:innen

PROTACchemoproteomicsmolecular glueproteomicstargeted protein degradation

Substanzen

Proteolysis Targeting ChimeraUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK. Electronic address: gsathe001@dundee.ac.uk.
  • MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK. Electronic address: g.sapkota@dundee.ac.uk.

Förderung

  • Medical Research Council

Zitieren

APA

Sathe, G., & Sapkota, G. P. (2023). Proteomic approaches advancing targeted protein degradation. Trends in Pharmacological Sciences, 44(11), 786-801. https://doi.org/10.1016/j.tips.2023.08.007

Vancouver

Sathe G, Sapkota GP. Proteomic approaches advancing targeted protein degradation. Trends in Pharmacological Sciences. 2023;44(11):786-801. doi:10.1016/j.tips.2023.08.007

BibTeX
@article{Sathe2023,
  author = {Sathe, Gajanan and Sapkota, Gopal P},
  title = {Proteomic approaches advancing targeted protein degradation},
  journal = {Trends in Pharmacological Sciences},
  year = {2023},
  volume = {44},
  number = {11},
  pages = {786--801},
  doi = {10.1016/j.tips.2023.08.007}
}
Kostenlos starten →